LOGIN  |  REGISTER
Recursion

Warby Parker Announces Third Quarter 2023 Results

November 08, 2023 | Last Trade: US$25.72 0.65 2.59
  • Net revenue increased 14.2% year over year to $169.8 million; Company raises outlook
  • Average Revenue per Customer increased 10.0% year over year to $284
  • Over 15 million pairs of glasses distributed through our Buy a Pair, Give a Pair program

NEW YORK / Nov 08, 2023 / Business Wire / Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced financial results for the third quarter ended September 30, 2023.

“In Q3, we were proud to deliver our strongest revenue growth year-to-date at 14.2%,” said Co-Founder and Co-CEO Neil Blumenthal. “Fueling topline results were 11 new store openings, four collection launches, contacts outperformance, and more. Customers continue to find exceptional value in our products, and we are focused on finding more ways to serve them through our growing and highly productive retail footprint, product innovation, and broader holistic vision care services.”

“As we head into the busiest time of year, our team remains laser focused on delivering remarkable experiences and value for our customers. We are confident in our strategic direction and continue to believe we are in the early innings of delivering long-term, profitable growth,” added Co-Founder and Co-CEO Dave Gilboa.

Third Quarter 2023 Highlights

  • Net revenue increased $21.1 million, or 14.2%, to $169.8 million.
  • GAAP net loss of $17.4 million.
  • Adjusted EBITDA(1) of $11.0 million and adjusted EBITDA margin(1) of 6.5%.
  • Over 15 million pairs of glasses have now been distributed to people in need through our Buy a Pair, Give a Pair program.

Third Quarter 2023 Year Over Year Financial Results

  • Net revenue increased $21.1 million, or 14.2%, to $169.8 million.
  • Average Revenue per Customer increased 10.0% to $284. Active Customers increased 1.8% to 2.30 million.
  • Gross profit increased 9.8% to $92.7 million.
  • Gross margin was 54.6% compared to 56.7% in the prior year period. The decline in gross margin was primarily driven by the growth of contact lenses, which carry lower gross margins than our other eyewear, increased costs associated with optometrists as we scale our eye exam offering across our fleet, and increases in store occupancy costs as a percent of revenue primarily due to increased depreciation and rent charges as we grew our store base to 227 stores, up from 190 in the prior year period.
  • Selling, general and administrative expenses (“SG&A”) were $112.5 million, up $4.4 million from the prior year, and represented 66.2% of revenue, down from 72.6% in the prior year period. Leverage in SG&A was primarily driven by reduced stock-based compensation costs and adjustments to our cost structure made last year, partially offset by increased marketing costs and technology costs. Adjusted SG&A(1) was $93.4 million, or 55.0% of revenue, versus $82.3 million, or 55.3% of revenue in the prior year period.
  • GAAP net loss improved $6.4 million to $17.4 million, primarily as a result of the increase in revenue described above.
  • Adjusted EBITDA(1) decreased $0.9 million to $11.0 million and adjusted EBITDA margin(1) decreased 1.5 points to 6.5%.
  • Opened 11 new stores during the quarter, ending Q3 with 227 stores.

Balance Sheet Highlights

Warby Parker ended the third quarter of 2023 with $216.0 million in cash and cash equivalents.

2023 Outlook

For the full year 2023, Warby Parker is revising guidance to be as follows:

  • Net revenue of $666 to $669 million, representing growth of approximately 11.5% at the midpoint versus full year 2022.
  • Adjusted EBITDA(1) of approximately $52.7 million, or adjusted EBITDA margin(1) of 7.9%.
  • On track for 40 new store openings this year.

“While both our top and bottom line exceeded our prior outlook for the third quarter, we are cognizant of headwinds facing the consumer in the current macro environment,” said Chief Financial Officer Steve Miller. “Given our outperformance year-to-date, we are raising our full year revenue guidance and maintaining a disciplined approach to spend.”

The guidance and forward-looking statements made in this press release and on our conference call are based on management's expectations as of the date of this press release.

(1) Please see the reconciliation of non-GAAP financial measures to the most comparable GAAP financial measure in the section titled “Non-GAAP Financial Measures” below.

Webcast and Conference Call

A conference call to discuss Warby Parker’s third quarter 2023 results, as well as fourth quarter and full year 2023 outlook, is scheduled for 8:00 a.m. ET today. To participate, please dial 833-470-1428 from the U.S. or 646-904-5544 from international locations. The conference passcode is 323975. A live webcast of the conference call will be available on the investors section of the Company’s website at investors.warbyparker.com where presentation materials will also be posted prior to the conference call. A replay will be made available online approximately two hours following the live call for a period of 90 days.

Forward-Looking Statements

This press release and the related conference call, webcast and presentation contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements may relate to, but are not limited to, expectations of future operating results or financial performance, including expectations regarding achieving profitability and growth in our e-commerce channel, delivering stakeholder value, growing market share, and our guidance for the quarter and year ending December 31, 2023; expectations regarding the number of new store openings during the year ending December 31, 2023; management’s plans, priorities, initiatives and strategies; and expectations regarding growth of our business. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “toward,” “will,” or “would,” or the negative of these words or other similar terms or expressions. You should not put undue reliance on any forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved, if at all.

Forward-looking statements are based on information available at the time those statements are made and are based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control, that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. These risks and uncertainties include our ability to manage our future growth effectively; our expectations regarding cost of goods sold, gross margin, channel mix, customer mix, and selling, general, and administrative expenses; increases in component and shipping costs and changes in supply chain; our reliance on our information technology systems and enterprise resource planning systems for our business to effectively operate and safeguard confidential information; our ability to engage our existing customers and obtain new customers; planned new retail stores in 2023 and going forward; an overall decline in the health of the economy and other factors impacting consumer spending, such as recessionary conditions, inflation, government instability, and geopolitical unrest; our ability to compete successfully; our ability to manage our inventory balances and shrinkage; the growth of our brand awareness; our ability to recruit and retain optometrists, opticians, and other vision care professionals; a resurgence of COVID-19 or the spread of new infectious diseases; the effects of seasonal trends on our results of operations; our ability to stay in compliance with extensive laws and regulations that apply to our business and operations; our ability to adequately maintain and protect our intellectual property and proprietary rights; our reliance on third parties for our products, operation and infrastructure; our duties related to being a public benefit corporation; the ability of our Co-Founders and Co-CEOs to exercise significant influence over all matters submitted to stockholders for approval; the effect of our multi-class structure on the trading price of our Class A common stock; and the increased expenses associated with being a public company. Additional information regarding these and other risks and uncertainties that could cause actual results to differ materially from the Company's expectations is included in our most recent reports filed with the SEC on Form 10-K and Form 10-Q. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

Additional information regarding these and other factors that could affect the Company’s results is included in the Company’s SEC filings, which may be obtained by visiting the SEC's website at www.sec.gov. Information contained on, or that is referenced or can be accessed through, our website does not constitute part of this document and inclusions of any website addresses herein are inactive textual references only.

Glossary

Active Customer is defined as a unique customer that has made at least one purchase of any product or service in the preceding 12-month period.

Average Revenue per Customer is defined as net revenue for a given period divided by the number of Active Customers as of the end of that same period.

Non-GAAP Financial Measures

We use adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted earnings per share, adjusted cost of goods sold (“adjusted COGS”), adjusted gross margin, adjusted gross profit, and adjusted selling, general, and administrative expenses (“adjusted SG&A”) as important indicators of our operating performance. Collectively, we refer to these non-GAAP financial measures as our “Non-GAAP Measures.” The Non-GAAP Measures, when taken collectively with our GAAP results, may be helpful to investors because they provide consistency and comparability with past financial performance and assist in comparisons with other companies, some of which use similar non-GAAP financial information to supplement their GAAP results.

Adjusted EBITDA is defined as net income (loss) before interest and other income, taxes, and depreciation and amortization as further adjusted for asset impairment costs, stock-based compensation expense and related employer payroll taxes, amortization of cloud-based software implementation costs, non-cash charitable donations, and non-recurring costs such as major system implementation costs and restructuring costs. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net revenue.

Adjusted net income (loss) is defined as net income (loss) adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, and non-recurring costs such as major system implementation costs and restructuring costs, and as further adjusted for estimated income tax on such adjusted items.

Adjusted earnings (loss) per share is defined as adjusted net income (loss) divided by adjusted weighted average shares outstanding.

Adjusted COGS is defined as cost of goods sold adjusted for stock-based compensation expense and related employer payroll taxes.

Adjusted gross profit is defined as net revenue minus adjusted COGS. Adjusted gross margin is defined as adjusted gross profit divided by net revenue.

Adjusted SG&A is defined as SG&A adjusted for stock-based compensation expense and related employer payroll taxes, non-cash charitable donations, and non-recurring costs such as major system implementation costs and restructuring costs.

The Non-GAAP Measures are presented for supplemental informational purposes only. A reconciliation of historical GAAP to Non-GAAP financial information is included under “Selected Financial Information” below.

We have not reconciled our adjusted EBITDA margin guidance to GAAP net income (loss) margin, or net margin, or adjusted EBITDA guidance to GAAP net income (loss) because we do not provide guidance for GAAP net margin or GAAP net income (loss) due to the uncertainty and potential variability of stock-based compensation and taxes, which are reconciling items between GAAP net margin and adjusted EBITDA margin and GAAP net income (loss) and adjusted EBITDA, respectively. Because such items cannot be reasonably provided without unreasonable efforts, we are unable to provide a reconciliation of the adjusted EBITDA margin guidance to GAAP net margin and adjusted EBITDA guidance to GAAP net income (loss). However, such items could have a significant impact on GAAP net margin and GAAP net income (loss).

About Warby Parker

Warby Parker (NYSE: WRBY) was founded in 2010 with a mission to inspire and impact the world with vision, purpose, and style–without charging a premium for it. Headquartered in New York City, the co-founder-led lifestyle brand pioneers ideas, designs products, and develops technologies that help people see, from designer-quality prescription glasses (starting at $95) and contacts, to eye exams and vision tests available online and in more than 200 retail stores across the U.S. and Canada.

Warby Parker aims to demonstrate that businesses can scale, do well, and do good in the world. Ultimately, the brand believes in vision for all, which is why for every pair of glasses or sunglasses sold, they distribute a pair to someone in need through their Buy a Pair, Give a Pair program. To date, Warby Parker has worked alongside its nonprofit partners to distribute more than 15 million glasses to people in need.

Selected Financial Information

Warby Parker Inc. and Subsidiaries

Consolidated Balance Sheets (Unaudited)

(Amounts in thousands, except share data)

    

 

September 30, 2023

 

December 31, 2022

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

215,965

 

 

$

208,585

 

Accounts receivable, net

 

721

 

 

 

1,435

 

Inventory

 

63,617

 

 

 

68,848

 

Prepaid expenses and other current assets

 

15,179

 

 

 

15,700

 

Total current assets

 

295,482

 

 

 

294,568

 

 

 

 

 

Property and equipment, net

 

151,109

 

 

 

138,628

 

Right-of-use lease assets

 

120,359

 

 

 

127,014

 

Other assets

 

7,929

 

 

 

8,497

 

Total assets

$

574,879

 

 

$

568,707

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

24,207

 

 

$

20,791

 

Accrued expenses

 

54,640

 

 

 

58,222

 

Deferred revenue

 

17,623

 

 

 

25,628

 

Current lease liabilities

 

23,086

 

 

 

22,546

 

Other current liabilities

 

2,254

 

 

 

2,370

 

Total current liabilities

 

121,810

 

 

 

129,557

 

 

 

 

 

Non-current lease liabilities

 

147,096

 

 

 

150,832

 

Other liabilities

 

1,362

 

 

 

1,672

 

Total liabilities

 

270,268

 

 

 

282,061

 

Commitments and contingencies

 

 

 

Stockholders’ equity:

 

 

 

Common stock, $0.0001 par value; Class A: 750,000,000 shares authorized at September 30, 2023 and December 31, 2022, 97,779,105 and 96,115,202 issued and outstanding at September 30, 2023 and December 31, 2022, respectively; Class B: 150,000,000 shares authorized at September 30, 2023 and December 31, 2022, 19,479,598 and 19,223,572 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively, convertible to Class A on a one-to-one basis

 

12

 

 

 

12

 

Additional paid-in capital

 

954,019

 

 

 

890,915

 

Accumulated deficit

 

(647,784

)

 

 

(603,634

)

Accumulated other comprehensive loss

 

(1,636

)

 

 

(647

)

Total stockholders’ equity

 

304,611

 

 

 

286,646

 

Total liabilities and stockholders’ equity

$

574,879

 

 

$

568,707

 

 

Warby Parker Inc. and Subsidiaries

Consolidated Statements of Operations (Unaudited)

(Amounts in thousands, except share and per share data)

    

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

Net revenue

$

169,849

 

 

$

148,777

 

 

$

507,910

 

 

$

451,619

 

Cost of goods sold

 

77,117

  

 

64,359

  

 

229,752

 

 

 

191,208

 

Gross profit

 

92,732

 

 

 

84,418

 

 

 

278,158

 

 

 

260,411

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expenses

 

112,499

 

 

 

108,090

 

 

 

328,585

 

 

 

349,904

 

Loss from operations

 

(19,767

)

 

 

(23,672

)

 

 

(50,427

)

 

 

(89,493

)

 

 

 

 

 

 

 

 

Interest and other income (loss), net

 

2,655

 

 

 

(183

)

 

 

6,815

 

 

 

(75

)

 

 

 

 

 

 

 

 

Loss before income taxes

 

(17,112

)

 

 

(23,855

)

 

 

(43,612

)

 

 

(89,568

)

Provision for income taxes

 

301

 

 

 

(12

)

 

 

538

 

 

 

574

 

Net loss

$

(17,413

)

 

$

(23,843

)

 

$

(44,150

)

 

$

(90,142

)

 

 

 

 

 

 

 

 

Net loss per share attributable to common stockholders, basic and diluted

$

(0.15

)

 

$

(0.21

)

 

$

(0.38

)

 

$

(0.79

)

Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted

 

118,003,640

 

 

 

115,249,431

 

 

 

116,995,545

 

 

 

114,681,893

 

  

Warby Parker Inc. and Subsidiaries

Consolidated Statements of Cash Flows (Unaudited)

(Amounts in thousands)

   

 

Nine Months Ended September 30,

 

 

2023

 

 

 

2022

 

Cash flows from operating activities

 

 

 

 

Net loss

$

(44,150

)

 

$

(90,142

)

Adjustments to reconcile net loss to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

28,184

 

 

 

22,947

 

Stock-based compensation

 

54,083

 

 

 

78,209

 

Non-cash charitable contribution

 

3,191

 

 

 

3,270

 

Asset impairment charges

 

1,407

 

 

 

1,509

 

Amortization of cloud-based software implementation costs

 

1,679

 

 

 

96

 

Change in operating assets and liabilities:

 

 

 

 

Accounts receivable, net

 

714

 

 

 

(126

)

Inventory

 

5,231

 

 

 

(13,522

)

Prepaid expenses and other assets

 

410

 

 

 

(4,546

)

Accounts payable

 

2,756

 

 

 

(9,209

)

Accrued expenses

 

(1,207

)

 

 

(4,319

)

Deferred revenue

 

(8,005

)

 

 

(5,796

)

Other current liabilities

 

(116

)

 

 

(6

)

Right-of-use lease assets and current and non-current lease liabilities

 

3,458

 

 

 

6,346

 

Other liabilities

 

(309

)

 

 

1,820

 

Net cash provided by (used in) operating activities

 

47,326

 

 

 

(13,469

)

Cash flows from investing activities

 

 

 

 

Purchases of property and equipment

 

(40,098

)

 

 

(45,966

)

Investment in optical equipment company

 

(1,000

)

 

 

 

Net cash used in investing activities

 

(41,098

)

 

 

(45,966

)

Cash flows from financing activities

 

 

 

 

Proceeds from stock option exercises

 

1,017

 

 

 

295

 

Proceeds from shares issued in connection with employee stock purchase plan

 

1,124

 

 

 

1,754

 

Proceeds from repayment of related party loans

 

 

 

45

 

Net cash provided by financing activities

 

2,141

 

 

 

2,094

 

Effect of exchange rates on cash

 

(989

)

 

 

(1,190

)

Net change in cash and cash equivalents

 

7,380

 

 

 

(58,531

)

Cash and cash equivalents, beginning of period

 

208,585

 

 

 

256,416

 

Cash and cash equivalents, end of period

$

215,965

 

 

$

197,885

 

Supplemental disclosures

 

 

 

 

Cash paid for income taxes

$

400

 

 

$

471

 

Cash paid for interest

 

155

 

 

 

89

 

Cash paid for amounts included in the measurement of lease liabilities

 

27,124

 

 

 

23,262

 

Non-cash investing and financing activities:

 

 

 

 

Purchases of property and equipment included in accounts payable and accrued expenses

$

5,941

 

 

$

4,819

 

Warby Parker Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

The following table reconciles adjusted EBITDA and adjusted EBITDA margin to the most directly comparable GAAP measure, which is net loss:

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

 

unaudited (in thousands)

 

unaudited (in thousands)

Net loss

$

(17,413

)

 

$

(23,843

)

 

$

(44,150

)

 

$

(90,142

)

Adjusted to exclude the following:

 

 

 

 

 

 

 

Interest and other income (loss), net

 

(2,655

)

 

 

183

 

 

 

(6,815

)

 

 

75

 

Provision for income taxes

 

301

 

 

 

(12

)

 

 

538

 

 

 

574

 

Depreciation and amortization expense

 

9,760

 

 

 

8,342

 

 

 

28,184

 

 

 

22,947

 

Asset impairment charges

 

757

 

 

 

1,097

 

 

 

1,407

 

 

 

1,509

 

Stock-based compensation expense(1)

 

16,466

 

 

 

24,358

 

 

 

54,496

 

 

 

78,603

 

Non-cash charitable donation(2)

 

2,591

 

 

 

 

 

 

3,191

 

 

 

3,270

 

Amortization of cloud-based software implementation costs(3)

 

853

 

 

 

96

 

 

 

1,679

 

 

 

96

 

ERP implementation costs(4)

 

371

 

 

 

170

 

 

 

4,413

 

 

 

170

 

Restructuring costs(5)

 

 

 

 

1,535

 

 

 

 

 

 

1,535

 

Adjusted EBITDA

 

11,031

 

 

 

11,926

 

 

 

42,943

 

 

 

18,637

 

Adjusted EBITDA margin

 

6.5

%

 

 

8.0

%

 

 

8.5

%

 

 

4.1

%

(1)

Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions. For the three months ended September 30, 2023 and 2022, the amount includes $0.2 million and $0.1 million, respectively, of employer payroll costs associated with releases of RSUs and option exercises. For both the nine months ended September 30, 2023 and 2022, the amount includes $0.4 million of employer payroll costs associated with releases of RSUs and option exercises.

(2)

Represents charitable expense recorded in connection with the donation of 56,938 shares of Class A common stock to charitable donor advised funds in June 2023 and 178,572 shares of Class A common stock in both August 2023 and May 2022 to the Warby Parker Impact Foundation.

(3)

Represents the amortization of costs capitalized in connection with the implementation of cloud-based software.

(4)

Represents internal and external non-capitalized costs related to the implementation of our new Enterprise Resource Planning (“ERP”) system.

(5)

Represents employee severance and related costs for our restructuring plan that was executed in August 2022.

Warby Parker Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

The following table presents our non-GAAP, or adjusted, financial measures for the periods presented as a percentage of revenue. Each cost and operating expense is adjusted for stock-based compensation expense and related employer payroll taxes and ERP implementation costs, if applicable.

 

Reported

 

Adjusted

 

Reported

 

Adjusted

 

Three Months Ended September 30,

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

 

(unaudited, in thousands)

 

(unaudited, in thousands)

 

(unaudited, in thousands)

 

(unaudited, in thousands)

Cost of goods sold

$

77,117

 

 

$

64,359

 

 

$

76,835

 

 

$

64,120

 

 

$

229,752

 

 

$

191,208

 

 

$

228,976

 

 

$

190,499

 

% of Revenue

 

45.4

%

 

 

43.3

%

 

 

45.2

%

 

 

43.1

%

 

 

45.2

%

 

 

42.3

%

 

 

45.1

%

 

 

42.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

$

92,732

 

 

$

84,418

 

 

$

93,014

 

 

$

84,657

 

 

$

278,158

 

 

$

260,411

 

 

$

278,934

 

 

$

261,120

 

% of Revenue

 

54.6

%

 

 

56.7

%

 

 

54.8

%

 

 

56.9

%

 

 

54.8

%

 

 

57.7

%

 

 

54.9

%

 

 

57.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expenses

$

112,499

 

 

$

108,090

 

 

$

93,353

 

 

$

82,266

 

 

$

328,585

 

 

$

349,904

 

 

$

267,261

 

 

$

267,035

 

% of Revenue

 

66.2

%

 

 

72.6

%

 

 

55.0

%

 

 

55.3

%

 

 

64.7

%

 

 

77.5

%

 

 

52.6

%

 

 

59.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

$

(17,413

)

 

$

(23,843

)

 

$

1,634

 

 

$

1,558

 

 

$

(44,150

)

 

$

(90,142

)

 

$

13,041

 

 

$

(4,225

)

% of Revenue

 

(10.3

)%

 

 

(16.0

)%

 

 

1.0

%

 

 

1.0

%

 

 

(8.7

)%

 

 

(20.0

)%

 

 

2.6

%

 

 

(0.9

)%

Warby Parker Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Measures (Unaudited)

The following table reflects a reconciliation of each non-GAAP, or adjusted, financial measure to its most directly comparable financial measure prepared in accordance with GAAP:

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

2023

 

 

 

2022

 

 

 

2023

 

 

 

2022

 

 

(unaudited, in thousands)

 

(unaudited, in thousands)

Cost of goods sold

$

77,117

 

 

$

64,359

 

 

$

229,752

 

 

$

191,208

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation expense(1)

 

282

 

 

 

239

 

 

 

776

 

 

 

709

 

Adjusted cost of goods sold

$

76,835

 

 

$

64,120

 

 

$

228,976

 

 

$

190,499

 

 

 

 

 

 

 

 

 

Gross profit

$

92,732

 

 

$

84,418

 

 

$

278,158

 

 

$

260,411

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation expense(1)

 

282

 

 

 

239

 

 

 

776

 

 

 

709

 

Adjusted gross profit

$

93,014

 

 

$

84,657

 

 

$

278,934

 

 

$

261,120

 

 

 

 

 

 

 

 

 

Selling, general, and administrative expenses

$

112,499

 

 

$

108,090

 

 

$

328,585

 

 

$

349,904

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation expense(1)

 

16,184

 

 

 

24,119

 

 

 

53,720

 

 

 

77,894

 

Non-cash charitable donation(2)

 

2,591

 

 

 

 

 

 

3,191

 

 

 

3,270

 

ERP implementation costs(3)

 

371

 

 

 

170

 

 

 

4,413

 

 

 

170

 

Restructuring costs(4)

 

 

 

 

1,535

 

 

 

 

 

 

1,535

 

Adjusted selling, general, and administrative expenses

$

93,353

 

 

$

82,266

 

 

$

267,261

 

 

$

267,035

 

 

 

 

 

 

 

 

 

Net loss

$

(17,413

)

 

$

(23,843

)

 

$

(44,150

)

 

$

(90,142

)

Provision for income taxes

 

301

 

 

 

(12

)

 

 

538

 

 

 

574

 

Loss before income taxes

 

(17,112

)

 

 

(23,855

)

 

 

(43,612

)

 

 

(89,568

)

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation expense(1)

 

16,466

 

 

 

24,358

 

 

 

54,496

 

 

 

78,603

 

Non-cash charitable donation(2)

 

2,591

 

 

 

 

 

 

3,191

 

 

 

3,270

 

ERP implementation costs(3)

 

371

 

 

 

170

 

 

 

4,413

 

 

 

170

 

Restructuring costs(4)

 

 

 

 

1,535

 

 

 

 

 

 

1,535

 

Adjusted provision for income taxes(5)

 

(682

)

 

 

(650

)

 

 

(5,447

)

 

 

1,765

 

Adjusted net income (loss)

$

1,634

 

 

$

1,558

 

 

$

13,041

 

 

$

(4,225

)

 

 

 

 

 

 

 

 

Adjusted weighted average shares - diluted

 

118,617,828

 

 

 

115,844,962

 

 

 

117,855,800

 

 

 

114,681,893

 

Adjusted diluted earnings (loss) per share

$

0.01

 

 

$

0.01

 

 

$

0.11

 

 

$

(0.04

)

(1)

Represents expenses related to the Company’s equity-based compensation programs and related employer payroll taxes, which may vary significantly from period to period depending upon various factors including the timing, number, and the valuation of awards granted, and vesting of awards including the satisfaction of performance conditions. For the three months ended September 30, 2023 and 2022, the amount includes $0.2 million and $0.1 million, respectively, of employer payroll costs associated with releases of RSUs and option exercises. For both the nine months ended September 30, 2023 and 2022, the amount includes $0.4 million of employer payroll costs associated with releases of RSUs and option exercises.

(2)

Represents charitable expense recorded in connection with the donation of 56,938 shares of Class A common stock to charitable donor advised funds in June 2023 and 178,572 shares of Class A common stock in both August 2023 and May 2022 to the Warby Parker Impact Foundation.

(3)

Represents internal and external non-capitalized costs related to the implementation of our new ERP system.

(4)

Represents employee severance and related costs for our restructuring plan that was executed in August 2022.

(5)

The adjusted provision for income taxes is based on long-term estimated annual effective tax rate 29.46% in both 2023 and 2022. The Company may adjust its adjusted tax rate as additional information becomes available or events occur which may materially affect this rate, including impacts from the rapidly evolving global tax environment, significant changes in our geographic mix, merger and acquisition activity, or changes in our business outlook.

 

Recursion

Stock Quote

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB